COZZI, VALERIA
COZZI, VALERIA
Dipartimento di Scienze Biomediche e Cliniche
Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients : a Call for Action?
2020 D. Cattaneo, M. Fusi, V. Cozzi, S. Baldelli, I. Bonini, C. Gervasoni, E. Clementi
Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living with HIV: A Narrative Review
2020 D. Cattaneo, S. Baldelli, V. Cozzi, E. Clementi, D.J. Marriott, C. Gervasoni
Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis
2019 D. Cattaneo, S. Baldelli, A. Giacomelli, D. Minisci, P. Meraviglia, N. Astuti, M. Fusi, V. Cozzi, E. Clementi, M. Galli, C. Gervasoni
High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis
2018 E. Arsiè, S. Piconi, M. Iavarone, V. Cozzi, P. Lampertico, D. Cattaneo
Development and Validation of a Chromatographic-UV Method for the Quantification of Isavuconazole in Human Plasma Samples
2018 V. Cozzi, S. Baldelli, S. Castoldi, E. Clementi, D. Cattaneo
Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid
2018 S. Castoldi, V. Cozzi, S. Baldelli, S. Fucile, E. Clementi, D. Cattaneo
Clinical and genetic determinants of nevirapine plasma trough concentration
2018 A. Giacomelli, S. Rusconi, F.S. Falvella, M.L. Oreni, D. Cattaneo, V. Cozzi, G. Renisi, E. Monge, S. Cheli, E. Clementi, A. Riva, M. Galli, A.L. Ridolfo
Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect?
2017 D. Cattaneo, D. Minisci, V. Cozzi, A. Riva, P. Meraviglia, E.G.I. Clementi, M. Galli, C. Gervasoni
Pharmacogenetics-based optimisation of atazanavir treatment : potential role of new genetic predictors
2017 F.S. Falvella, E. Ricci, S. Cheli, C. Resnati, V. Cozzi, D. Cattaneo, C. Gervasoni, E.G.I. Clementi, M. Galli, A. Riva
Effects of ritonavir and cobicistat on dolutegravir exposure : when the booster can make the difference
2017 C. Gervasoni, A. Riva, V. Cozzi, A.F. Capetti, G. Rizzardini, E.G.I. Clementi, D. Cattaneo
Therapeutic drug management of linezolid : a missed opportunity for clinicians?
2016 D. Cattaneo, C. Gervasoni, V. Cozzi, S. Castoldi, S. Baldelli, E. Clementi
Development and validation of a chromatographic ultraviolet method for the simultaneous quantification of dolutegravir and rilpivirine in human plasma
2016 V. Cozzi, N. Charbe, S. Baldelli, S. Castoldi, C. Atzori, D. Cattaneo, E. Clementi
Comparison of the QMS® analyzer with HPLC-UV for the quantification of lamotrigine concentrations in human plasma samples
2015 S. Baldelli, S. Castoldi, N. Charbe, V. Cozzi, S. Fucile, D. Cattaneo, E. Clementi
Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients : is it time to revise atazanavir dosages?
2015 C. Gervasoni, P. Meraviglia, D. Minisci, L. Ferraris, A. Riva, S. Landonio, V. Cozzi, N. Charbe, L. Molinari, G. Rizzardini, E. Clementi, M. Galli, D. Cattaneo
Is it time to revise linezolid doses in peritoneal dialysis patients? A case series
2015 C. Gervasoni, R. Bergia, V. Cozzi, E. Clementi, D. Cattaneo
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers
2014 M.V. Cossu, D. Cattaneo, S. Fucile, P. Pellegrino, S. Baldelli, V. Cozzi, A. Capetti, E. Clementi
Is it time to revise antiretrovirals dosing? : a pharmacokinetic viewpoint
2014 D. Cattaneo, S. Baldelli, S. Castoldi, N. Charbe, V. Cozzi, S. Fucile, E. Clementi
Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections
2013 D. Cattaneo, G. Orlando, V. Cozzi, L. Cordier, S. Baldelli, S. Merli, S. Fucile, C. Gulisano, G. Rizzardini, E.G.I. Clementi
Limited sampling strategies for the estimation of atazanavir daily exposure in HIV-infected patients
2013 D. Cattaneo, D. Ripamonti, S. Baldelli, V. Cozzi, S. Fucile, E. Clementi
Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients
2012 D. Cattaneo, C. Gervasoni, V. Cozzi, S. Baldelli, S. Fucile, P. Meraviglia, S. Landonio, G. Boreggio, G. Rizzardini, E.G.I. Clementi